DGS Capital Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$208K Buy
+11,899
New +$236K 0.03% 549
2024
Q2
Sell
-7,258
Closed -$352K 322
2024
Q1
$352K Buy
7,258
+2,773
+62% +$136K 0.1% 184
2023
Q4
$240K Sell
4,485
-3,159
-41% -$160K 0.09% 197
2023
Q3
$448K Sell
7,644
-57
-0.7% -$3.56K 0.22% 103
2023
Q2
$485K Buy
7,701
+866
+13% +$55.2K 0.24% 92
2023
Q1
$430K Buy
6,835
+2,290
+50% +$137K 0.24% 93
2022
Q4
$242K Buy
+4,545
New +$246K 0.16% 173
2022
Q3
Sell
-4,031
Closed -$292K 223
2022
Q2
$292K Buy
+4,031
New +$300K 0.24% 110

Other funds holding USNA

DGS Capital Management's USNA Position: Q1 2026 in Review

DGS Capital Management opened a new position in Usana Health Sciences (USNA) in Q1 2026: 11,899 shares worth $208K. The stake represents 0.03% of the portfolio and ranks #549 among its holdings. This is a return to the name: DGS Capital Management previously reported a position in USNA as recently as Q1 2024.

DGS Capital Management first reported a position in USNA in Q2 2022 and has held it in 8 quarters since. The position peaked at $485K in Q2 2023. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • DGS Capital Management held 11,899 shares of Usana Health Sciences worth $208K as of Q1 2026.
  • Usana Health Sciences was a new DGS Capital Management position in Q1 2026.
  • Usana Health Sciences made up 0.03% of DGS Capital Management's portfolio in Q1 2026, its #549 holding.
  • DGS Capital Management first reported a position in Usana Health Sciences in Q2 2022 and has held it in 8 quarters since.
  • DGS Capital Management's Usana Health Sciences position peaked at $485K in Q2 2023.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.